| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aid agencies turn attention to diabetes
|
Devi, Sharmila
|
|
|
397 |
10279 |
p. 1049-1050
|
artikel
|
| 2 |
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
|
Manisty, Charlotte
|
|
|
397 |
10279 |
p. 1057-1058
|
artikel
|
| 3 |
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
|
|
|
|
397 |
10279 |
p. 1063-1074
|
artikel
|
| 4 |
Biden's first legislative victory: $1·9 trillion for COVID-19
|
Jaffe, Susan
|
|
|
397 |
10279 |
p. 1047-1048
|
artikel
|
| 5 |
Call to action: how can the US Ending the HIV Epidemic initiative succeed?
|
Beyrer, Chris
|
|
|
397 |
10279 |
p. 1151-1156
|
artikel
|
| 6 |
Chris Butler: primary care research supremo
|
Lane, Richard
|
|
|
397 |
10279 |
p. 1051
|
artikel
|
| 7 |
Control vaccine formulation
|
Doshi, Peter
|
|
|
397 |
10279 |
p. 1061-1062
|
artikel
|
| 8 |
Control vaccine formulation – Authors' reply
|
Saah, Alfred J
|
|
|
397 |
10279 |
p. 1062
|
artikel
|
| 9 |
COVID-19, community trials, and inclusion
|
Gill, Paramjit S
|
|
|
397 |
10279 |
p. 1036-1037
|
artikel
|
| 10 |
Dame Fiona Caldicott
|
Watts, Geoff
|
|
|
397 |
10279 |
p. 1056
|
artikel
|
| 11 |
Documenting the struggle for reproductive justice and rights
|
Hallgarten, Lisa
|
|
|
397 |
10279 |
p. 1052-1053
|
artikel
|
| 12 |
Ending the HIV epidemic in US Latinx sexual and gender minorities
|
Rodriguez-Diaz, Carlos E
|
|
|
397 |
10279 |
p. 1043-1045
|
artikel
|
| 13 |
Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses
|
Sullivan, Patrick S
|
|
|
397 |
10279 |
p. 1095-1106
|
artikel
|
| 14 |
18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine
|
Steinberg, Julie
|
|
|
397 |
10279 |
p. e9
|
artikel
|
| 15 |
HIV and women in the USA: what we know and where to go from here
|
Adimora, Adaora A
|
|
|
397 |
10279 |
p. 1107-1115
|
artikel
|
| 16 |
Human flourishing in a health-creating society
|
Crisp, Nigel
|
|
|
397 |
10279 |
p. 1054-1055
|
artikel
|
| 17 |
Insurance coverage and financing landscape for HIV treatment and prevention in the USA
|
Kates, Jennifer
|
|
|
397 |
10279 |
p. 1127-1138
|
artikel
|
| 18 |
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data
|
Figtree, Gemma A
|
|
|
397 |
10279 |
p. 1085-1094
|
artikel
|
| 19 |
Myanmar's democracy and health on life support
|
The Lancet,
|
|
|
397 |
10279 |
p. 1035
|
artikel
|
| 20 |
Osteoarthritis in 2020 and beyond
|
Pigeolet, Manon
|
|
|
397 |
10279 |
p. 1059-1060
|
artikel
|
| 21 |
Osteoarthritis in 2020 and beyond – Authors' reply
|
Hunter, David J
|
|
|
397 |
10279 |
p. 1060
|
artikel
|
| 22 |
Roll-out of the Global Burden of Animal Diseases programme
|
Rushton, J
|
|
|
397 |
10279 |
p. 1045-1046
|
artikel
|
| 23 |
Same script, different viruses: HIV and COVID-19 in US Black communities
|
Fields, Errol L
|
|
|
397 |
10279 |
p. 1040-1042
|
artikel
|
| 24 |
Satiation or satiety? More than mere semantics
|
Klaassen, Tim
|
|
|
397 |
10279 |
p. 1060-1061
|
artikel
|
| 25 |
Satiation or satiety? More than mere semantics – Authors' reply
|
Carbone, M Florencia
|
|
|
397 |
10279 |
p. 1061
|
artikel
|
| 26 |
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
|
He, Zhenyu
|
|
|
397 |
10279 |
p. 1075-1084
|
artikel
|
| 27 |
Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2
|
Strugnell, Richard
|
|
|
397 |
10279 |
p. 1037-1039
|
artikel
|
| 28 |
The opioid crisis and HIV in the USA: deadly synergies
|
Hodder, Sally L
|
|
|
397 |
10279 |
p. 1139-1150
|
artikel
|
| 29 |
The persistent and evolving HIV epidemic in American men who have sex with men
|
Mayer, Kenneth H
|
|
|
397 |
10279 |
p. 1116-1126
|
artikel
|
| 30 |
The risk of no risk in STEMI
|
Lønnebakken, Mai Tone
|
|
|
397 |
10279 |
p. 1039-1040
|
artikel
|
| 31 |
Undoing supremacy in global health will require more than decolonisation
|
Allotey, Pascale
|
|
|
397 |
10279 |
p. 1058
|
artikel
|
| 32 |
Undoing supremacy in global health will require more than decolonisation
|
Gedela, Keerti
|
|
|
397 |
10279 |
p. 1058
|
artikel
|
| 33 |
Undoing supremacy in global health will require more than decolonisation – Authors' reply
|
Abimbola, Seye
|
|
|
397 |
10279 |
p. 1058-1059
|
artikel
|
Tijdschrift beschrijving